Emerald Investment Advisers LLC Takes Position in Danaher Corporation $DHR

Emerald Investment Advisers LLC purchased a new stake in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 16,065 shares of the conglomerate’s stock, valued at approximately $11,567,000. Danaher makes up approximately 0.8% of Emerald Investment Advisers LLC’s portfolio, making the stock its 29th largest holding.

A number of other hedge funds have also bought and sold shares of the business. Westpac Banking Corp acquired a new stake in Danaher in the 2nd quarter worth about $1,330,000. Iyo Bank Ltd. acquired a new position in shares of Danaher during the 2nd quarter worth approximately $3,116,000. TRB Wealth Management LLC bought a new position in shares of Danaher during the second quarter worth approximately $460,000. Sumitomo Life Insurance Co. bought a new stake in shares of Danaher in the second quarter valued at approximately $1,255,000. Finally, Landscape Capital Management L.L.C. acquired a new stake in Danaher during the second quarter worth approximately $545,000. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have commented on DHR. TD Cowen lowered their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Wells Fargo & Company reduced their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Argus decreased their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Finally, Stifel Nicolaus dropped their price target on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Stock Performance

Shares of NYSE:DHR opened at $219.42 on Friday. The company’s 50 day simple moving average is $195.80 and its 200 day simple moving average is $192.61. The stock has a market capitalization of $154.25 billion, a price-to-earnings ratio of 38.97, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.77 earnings per share. As a group, research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.